Pharming (PHAR) Total Current Liabilities (2019 - 2025)

Pharming's Total Current Liabilities history spans 7 years, with the latest figure at $115.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $115.8 million for Q4 2025, up 56.89% from a year ago — trailing twelve months through Dec 2025 was $115.8 million (up 56.89% YoY), and the annual figure for FY2025 was $115.8 million, up 56.89%.
  • Total Current Liabilities for Q4 2025 was $115.8 million at Pharming, up from $73.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $115.8 million in Q4 2025 to a low of $46.8 million in Q4 2021.
  • The 5-year median for Total Current Liabilities is $73.8 million (2024), against an average of $74.8 million.
  • The sharpest move saw Total Current Liabilities crashed 37.31% in 2021, then soared 56.89% in 2025.
  • Year by year, Total Current Liabilities stood at $46.8 million in 2021, then rose by 27.64% to $59.7 million in 2022, then skyrocketed by 30.6% to $78.0 million in 2023, then decreased by 5.34% to $73.8 million in 2024, then skyrocketed by 56.89% to $115.8 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $115.8 million, $73.8 million, and $78.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.